Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026)

Integer Holdings' (ITGR) quarterly Cash from Financing Activities came in at $3.8 million in Q2 2026, down 97.47% year-on-year from $151.6 million in Q2 2025, and up 106.21% quarter-over-quarter from -$61.7 million in Q4 2025.

Integer Holdings (ITGR) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Integer Holdings has disclosed Cash from Financing Activities across 17 years of filings, most recently posting $3.8 million for Q2 2026.

  • Cash from Financing Activities for Q2 2026 came in at $3.8 million, down 97.47% year-over-year; the trailing twelve-month figure through Apr 2026 was -$104.2 million (down 6591.59% YoY), and the FY2025 annual result was $43.6 million, up 226.99% from the prior year.
  • Cash from Financing Activities came in at $3.8 million for Q2 2026 at Integer Holdings, up from -$61.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $163.3 million in Q1 2024 to a low of -$82.3 million in Q4 2024.
  • The 5-year median for Cash from Financing Activities is -$10.7 million (2025), against an average of $8.0 million.
  • Across the five-year window, Cash from Financing Activities surged 3321.4% in 2023 and tumbled 569.69% in 2024, its largest moves.
  • Integer Holdings' Cash from Financing Activities stood at -$13.9 million in 2022, then jumped by 225.74% to $17.5 million in 2023, then sank by 569.69% to -$82.3 million in 2024, then rose by 25.01% to -$61.7 million in 2025, then surged by 106.21% to $3.8 million in 2026.
  • The last three Cash from Financing Activities figures came in at $3.8 million (Q2 2026), -$61.7 million (Q4 2025), and -$10.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Integer Holdings 3.12 Bn 3.11 Bn 109.60 Mn 3.83 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 3.83 Mn
Apr 3, 2026 3.83 Mn
Dec 31, 2025 -61.72 Mn
Dec 31, 2025 -61.72 Mn
Sep 26, 2025 -10.71 Mn
Sep 26, 2025 -10.71 Mn
Jun 27, 2025 -35.59 Mn
Jun 27, 2025 -35.59 Mn
Mar 28, 2025 151.58 Mn
Mar 28, 2025 151.58 Mn
Dec 31, 2024 -82.30 Mn
Dec 31, 2024 -82.30 Mn
Sep 27, 2024 -43.14 Mn
Sep 27, 2024 -43.14 Mn
Jun 28, 2024 -24.53 Mn
Jun 28, 2024 -24.53 Mn
Mar 29, 2024 163.29 Mn
Mar 29, 2024 163.29 Mn
Dec 31, 2023 17.52 Mn
Dec 31, 2023 17.52 Mn